Middle-out sequence confirmation of CRISPR/Cas9 single guide RNA (sgRNA) using DNA primers and ribonuclease T1 digestion
Analytical and Bioanalytical Chemistry · 2023
DOI: 10.1007/s00216-023-04693-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical and Bioanalytical Chemistry, 2023. Verfasst von Steven Chin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Small Molecule Analytical Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, RNA, Guide, CRISPR-Cas Systems. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
Accurate sequencing of single guide RNAs (sgRNAs) for CRISPR/Cas9 genome editing is critical for patient safety, as the sgRNA guides the Cas9 nuclease to target site-specific cleavages in DNA. An approach to fully sequence sgRNA using protective DNA primers followed by ribonuclease (RNase) T1 digestion was developed to facilitate the analysis of these larger molecules by hydrophilic interaction liquid chromatography coupled with high-resolution mass spectrometry (HILIC-HRMS). Without RNase digestion, top-down mass spectrometry alone struggles to properly fragment precursor ions in large RNA oligonucleotides to provide confidence in sequence coverage. With RNase T1 digestion of these larger oligonucleotides, however, bottom-up analysis cannot confirm full sequence coverage due to the presence of short, redundant digestion products. By combining primer protection with RNase T1 digestion, digestion products are large enough to prevent redundancy and small enough to provide base resolution by tandem mass spectrometry to allow for full sgRNA sequence coverage. An investigation into the general requirements for adequate primer protection of specific regions of the RNA was conducted, followed by the development of a generic protection and digestion strategy that may be applied to different sgRNA sequences. This middle-out technique has the potential to expedite accurate sequence confirmation of chemically modified sgRNA oligonucleotides.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Small Molecule Analytical Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.
- Department of Small Molecule Analytical Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA. kurita.kenji@gene.com.
Zitieren
APA
Chin, S., Goyon, A., Zhang, K., & Kurita, K. L. (2023). Middle-out sequence confirmation of CRISPR/Cas9 single guide RNA (sgRNA) using DNA primers and ribonuclease T1 digestion. Analytical and Bioanalytical Chemistry. https://doi.org/10.1007/s00216-023-04693-9
Vancouver
Chin S, Goyon A, Zhang K, Kurita KL. Middle-out sequence confirmation of CRISPR/Cas9 single guide RNA (sgRNA) using DNA primers and ribonuclease T1 digestion. Analytical and Bioanalytical Chemistry. 2023. doi:10.1007/s00216-023-04693-9
BibTeX
@article{Chin2023,
author = {Chin, Steven and Goyon, Alexandre and Zhang, Kelly and Kurita, Kenji L},
title = {Middle-out sequence confirmation of CRISPR/Cas9 single guide RNA (sgRNA) using DNA primers and ribonuclease T1 digestion},
journal = {Analytical and Bioanalytical Chemistry},
year = {2023},
doi = {10.1007/s00216-023-04693-9}
}
EUVIMED